Formononetin as a Natural Product-Derived Candidate for Diabetic Microvascular Complications: Mechanistic Evidence, Pharmacokinetics, Formulation Strategies, and Translational Barriers
- DOI
- 10.2147/dddt.s623611
- Published
- 2026-10
- Container
- Drug Design, Development and Therapy
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2147/dddt.s623611,
title = {Formononetin as a Natural Product-Derived Candidate for Diabetic Microvascular Complications: Mechanistic Evidence, Pharmacokinetics, Formulation Strategies, and Translational Barriers},
author = {Xiaotian Gao and Yingtao Zhang and Yan Zheng and Luying Qiao and Xiaoling Liu and Sifan Yang and Xun Chen and Yunming Xiao and Xu Wang and Ran Liu and Zheyi Dong and Qian Wang and Xiangmei Chen and Quan Hong},
year = {2026},
journal = {Drug Design, Development and Therapy},
doi = {10.2147/dddt.s623611},
url = {https://doi.org/10.2147/dddt.s623611}
}RIS
TY - JOUR TI - Formononetin as a Natural Product-Derived Candidate for Diabetic Microvascular Complications: Mechanistic Evidence, Pharmacokinetics, Formulation Strategies, and Translational Barriers AU - Xiaotian Gao AU - Yingtao Zhang AU - Yan Zheng AU - Luying Qiao AU - Xiaoling Liu AU - Sifan Yang AU - Xun Chen AU - Yunming Xiao AU - Xu Wang AU - Ran Liu AU - Zheyi Dong AU - Qian Wang AU - Xiangmei Chen AU - Quan Hong PY - 2026 JO - Drug Design, Development and Therapy DO - 10.2147/dddt.s623611 UR - https://doi.org/10.2147/dddt.s623611 ER -
APA
Gao, X., Zhang, Y., Zheng, Y., Qiao, L., Liu, X., Yang, S., Chen, X., Xiao, Y., Wang, X., Liu, R., Dong, Z., Wang, Q., Chen, X., & Hong, Q. (2026). Formononetin as a Natural Product-Derived Candidate for Diabetic Microvascular Complications: Mechanistic Evidence, Pharmacokinetics, Formulation Strategies, and Translational Barriers. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s623611
Source records
- crossref · retrieved 2026-11-05T07:01:16.197Z